TrialMedicine2016

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

Warren Dinges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.